The store will not work correctly when cookies are disabled.
2-(Oxiran-2-ylmethylthio)-6-oxo-4-phenyl-1,6-dihydropyrimidine-5-carbonitrile
ID: ALA2415035
PubChem CID: 135958438
Max Phase: Preclinical
Molecular Formula: C14H11N3O2S
Molecular Weight: 285.33
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: N#Cc1c(-c2ccccc2)nc(SCC2CO2)[nH]c1=O
Standard InChI: InChI=1S/C14H11N3O2S/c15-6-11-12(9-4-2-1-3-5-9)16-14(17-13(11)18)20-8-10-7-19-10/h1-5,10H,7-8H2,(H,16,17,18)
Standard InChI Key: YCDJLQBONRDUES-UHFFFAOYSA-N
Molfile:
RDKit 2D
20 22 0 0 0 0 0 0 0 0999 V2000
8.6029 -1.5709 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6029 -2.3925 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3201 -2.8076 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0331 -2.3925 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.0331 -1.5709 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3201 -1.1558 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.7461 -1.1558 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
7.8899 -1.1558 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.8899 -2.8076 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3201 -3.6293 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1769 -3.2184 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.4591 -1.5709 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1763 -1.1558 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9980 -1.1558 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5872 -0.4427 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.6029 -4.0443 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6029 -4.8660 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3201 -5.2810 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0331 -4.8660 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0331 -4.0443 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 2 0
5 6 1 0
6 1 1 0
5 7 1 0
1 8 2 0
2 9 1 0
3 10 1 0
9 11 3 0
7 12 1 0
12 13 1 0
13 14 1 0
14 15 1 0
15 13 1 0
10 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 10 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 285.33 | Molecular Weight (Monoisotopic): 285.0572 | AlogP: 1.80 | #Rotatable Bonds: 4 |
Polar Surface Area: 82.07 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 6.80 | CX Basic pKa: ┄ | CX LogP: 1.56 | CX LogD: 1.02 |
Aromatic Rings: 2 | Heavy Atoms: 20 | QED Weighted: 0.53 | Np Likeness Score: -1.48 |
References
1. Fargualy AM, Habib NS, Ismail KA, Hassan AM, Sarg MT.. (2013) Synthesis, biological evaluation and molecular docking studies of some pyrimidine derivatives., 66 [PMID:23811090] [10.1016/j.ejmech.2013.05.028] |